Publications

Detailed Information

Regulation of adipogenesis via NEDDylation of PPARg and discovery of a novel anti-obesity agent to target this mechanism : PPARg와 NEDD8의 결합에 의한 지방세포 분화 조절기전의 연구 및 이를 표적으로 하는 새로운 비만 치료제의 발굴

DC Field Value Language
dc.contributor.advisor전양숙-
dc.contributor.author박형숙-
dc.date.accessioned2017-07-14T01:43:13Z-
dc.date.available2018-03-30-
dc.date.issued2015-02-
dc.identifier.other000000025400-
dc.identifier.urihttps://hdl.handle.net/10371/122279-
dc.description학위논문 (박사)-- 서울대학교 대학원 : 의과학과, 2015. 2. 전양숙.-
dc.description.abstractNeural precursor cell expressed developmentally down-regulated 8 (NEDD8), an ubiquitin-like protein, regulates the activity, stability, and subcellular localization of target proteins. NEDD8 is covalently conjugated to lysine residues of substrates though E1-E2-E3 enzyme cascades, which is called NEDDylation. Here, I characterized the prominent role of NEDDylation for adipogenesis. The depletion of NEDD8 decreased the expression of adipogenic genes, thereby inhibiting adipogenic differentiation. In particular, the expression of peroxisome proliferator-activated receptor gamma (PPARg), a master regulator of adipogenesis, was reduced by knocking down NEDD8, and was enhanced by over-expressing NEDD8 in 3T3-L1 cells. Moreover, PPARg covalently conjugated with NEDD8 during adipogenesis, as shown by Ni2+ pull-down assay with His-NEDD8-overexpressed 3T3-L1 cells. In addition, the stability of PPARg protein was sustained due to decreased ubiquitination during adipogenesis. Notably, mouse double minute 2 (MDM2) was found to be a specific E3 ligase of PPARg NEDDylation. Based on these results, I tested whether a NEDD8-activating enzyme inhibitor, MLN4924, had an anti-obesity effect. The results showed that MLN4924 can inhibit both adipocyte differentiation and fat accumulation in both 3T3-L1 cells and human adipocyte-derived stem cells (H-ADSCs). Consistently, MLN4924 treatment in diet-induced-obesity (DIO) mice model diminished weight gain, accompanied with recovered lipid metabolism to a normal range. Furthermore, MLN4924 treatment in DIO mice recovered glucose tolerance, insulin sensitivity, body weight, leptin level, and the expression of inflammatory cytokine genes. Taken together, these results suggest that NEDD8 leads to crucial post-translational modification to regulate the stability of PPARg proteins in adipogenesis. Accordingly, I report that MLN4924 could be developed as a therapeutic agent for obesity.-
dc.description.tableofcontentsAbstracts in English…………………………………ⅰ
Contents………………………………………………ⅲ
List of Figures…………………………………………ⅳ
List of Abbreviations…………………………………ⅶ
Introduction……………………………………………1
Materials and Methods………………………………5
Results…………………………………………………20
Discussion……………………………………………83
References……………………………………………91
Abstract in Korean…………………………………101
-
dc.formatapplication/pdf-
dc.format.extent7314864 bytes-
dc.format.mediumapplication/pdf-
dc.language.isoen-
dc.publisher서울대학교 대학원-
dc.subjectadipocyte differentiation-
dc.subjectPPARg-
dc.subjectNEDDylation-
dc.subjectMDM2-
dc.subjectMLN4924-
dc.subjectobesity.-
dc.subject.ddc610-
dc.titleRegulation of adipogenesis via NEDDylation of PPARg and discovery of a novel anti-obesity agent to target this mechanism-
dc.title.alternativePPARg와 NEDD8의 결합에 의한 지방세포 분화 조절기전의 연구 및 이를 표적으로 하는 새로운 비만 치료제의 발굴-
dc.typeThesis-
dc.contributor.AlternativeAuthorPark Hyoung Sook-
dc.description.degreeDoctor-
dc.citation.pagesⅶ,102-
dc.contributor.affiliation의과대학 의과학과-
dc.date.awarded2015-02-
Appears in Collections:
Files in This Item:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share